Citation:Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al 2018

Citation

Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. J Clin Oncol 2018 Jul 1;36(19):1981-1990 Available from: http://www.ncbi.nlm.nih.gov/pubmed/29718793.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al 2018	Ovarian suppression during chemotherapy	Dr Wanyuan Cui MBBS BMEDSCI FRACP	completed

Compare quality appraisals for each clinical question

• [[Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?|]] (compare critical appraisals)

Cited by

1. Ovarian suppression with GnRH analogues